
On May 20, 2026, Josh Zwagil officially sold his AkashX business network to Conectiv, a platform under Investview.
According to an Investview press release dated May 18, 2026, Josh Zwagil and the entire AkashX community have now joined the Conectiv platform.
This move comes seven months after Zwagil sold My Daily Choice to Immunotec.
AkashX, which was launched under My Daily Choice, was not included in the Immunotec deal. The exact details of the My Daily Choice acquisition remain unclear, as neither company made a formal public announcement.
In March 2026, a HempWorx distributor confirmed the acquisition of My Daily Choice by Immunotec. However, both companies stayed silent on the matter. My Daily Choice website is now disabled with no mention of Immunotec.
Industry observers note that AkashX aligns more closely with Investview’s Conectiv than with Immunotec.
Immunotec focuses on nutritional supplements, while Investview and Conectiv have a background in financial products. AkashX shifted from supplements to securities and trading tools in 2020.
AkashX faced several challenges in recent years:
Investview has a long history of regulatory issues involving commodities and securities in the US and Canada.
In January 2026, Poland fined the company $4 million for alleged pyramid scheme activities related to iGenius. Shortly after, iGenius announced it was rebranding to Conectiv in December 2025.
Chad Garner, President of Conectiv, welcomed the addition:
“We are thrilled to welcome Josh and the AkashX community to Conectiv.”
This latest development shows Zwagil moving from the supplement space into financial services through Conectiv.
